Compass Pathways Leads Innovation in Psilocybin-Based Depression Treatment
Compass Pathways Plc is a UK-based pharmaceutical company pioneering the use of psilocybin for treatment-resistant depression, with a strong focus on innovation and a promising future in the mental health sector.
2 minutes to read